A Biodegradable Iridium(III) Coordination Polymer for Enhanced Two-Photon Photodynamic Therapy Using an Apoptosis-Ferroptosis Hybrid Pathway

Angew Chem Int Ed Engl. 2022 Jul 11;61(28):e202205429. doi: 10.1002/anie.202205429. Epub 2022 May 24.

Abstract

The clinical application of photodynamic therapy is hindered by the high glutathione concentration, poor cancer-targeting properties, poor drug loading into delivery systems, and an inefficient activation of the cell death machinery in cancer cells. To overcome these limitations, herein, the formulation of a promising IrIII complex into a biodegradable coordination polymer (IrS NPs) is presented. The nanoparticles were found to remain stable under physiological conditions but deplete glutathione and disintegrate into the monomeric metal complexes in the tumor microenvironment, causing an enhanced therapeutic effect. The nanoparticles were found to selectively accumulate in the mitochondria where these trigger cell death by hybrid apoptosis and ferroptosis pathways through the photoinduced production of singlet oxygen and superoxide anion radicals. This study presents the first example of a coordination polymer that can efficiently cause cancer cell death by apoptosis and ferroptosis upon irradiation, providing an innovative approach for cancer therapy.

Keywords: Bioinorganic Chemistry; Iridium; Medicinal Inorganic Chemistry; Metals in Medicine; Photodynamic Therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Line, Tumor
  • Coordination Complexes* / pharmacology
  • Coordination Complexes* / therapeutic use
  • Ferroptosis*
  • Glutathione
  • Iridium / pharmacology
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Polymers / pharmacology

Substances

  • Coordination Complexes
  • Photosensitizing Agents
  • Polymers
  • Iridium
  • Glutathione